2018-07-12
Legal Press releases
Intervacc has been awarded funding through the Eurostars-2 program for further development of a vaccine against severe infection of piglets caused by Streptococcus suis. The Eurostars-2 program, a part of EU:s ... Read more
2018-07-09
Legal Press releases
Strangvac® is Intervacc's vaccine against strangles, which is a very severe and contagious infection in the horse. Intervacc has previously signed an agreement with 3P Biopharmaceuticals in Pamplona, Spain for large-scale commercial ... Read more
2018-06-01
Legal Press releases
The Nomination Committee hereby announces its proposal regarding the Chairman of the Board of Directors and other Board members to the Annual General Meeting of Intervacc AB (publ) on June 14th, 2018.
The ... Read more
2018-04-13
News
In a pressrelease distributed April 12, 2018 Intervacc presented information about the outcome of the preferential share issue of Intervacc AB (publ) ("Intervacc" or "Company") that was announced on February 18, 2018. ... Read more
2017-09-25
News
"Getting to grips with strangles" is a regularly recurring international scientific meeting on research on strangles a highly contagious horse disease. At the meeting held in Montanan, USA, in September 2017, Intervacc's CEO, Jan-Ingmar Flock, ... Read more
2017-08-01
News
The WEAS (World Equine Airway Symposium) is a regularly recurring international ... Read more